Anzeige
Mehr »
Login
Mittwoch, 15.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Uran-Rallye: Preise ziehen wieder an - Jetzt nicht den Einstieg verpassen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESSWIRE
668 Leser
Artikel bewerten:
(2)

unice lab: UNICE: Bridging Gaps in Healthcare Through Blockchain and AI

SEOUL, NORTH KOREA / ACCESSWIRE / March 17, 2024 / Recently, the blockchain-based artificial intelligence messaging service 'UNICE' has been selected as an ecosystem project by many global VCs. UNICE Lab, founded by medical professionals and medical school professors from Korea, aims to develop 'UNICE,' an AI that can handle everything from early disease diagnosis to treatment, and even surgery.

This UNICE service, an AI-based blockchain messenger trained by doctors, analyzes users' conversation and voice data to assess their mental and physical health status, providing customized healthcare solutions based on this analysis. The UNICE AI doctor is capable of early diagnosis, health management, customized treatment and prescription, and if necessary, surgical intervention, heralding a new era of proactive healthcare. Particularly, it aims to provide high-quality medical services to regions and vulnerable groups lacking medical resources, through integration with globally recognized robotic surgical systems such as da Vinci, MAKO, and Senhance.

The UNICE project builds a vast medical database based on user participation, generating added value such as tailored advertising for pharmaceutical companies, hospitals, and medical firms, as well as linking hospitals with actual patients. All these services leverage blockchain technology to enhance data reliability and security, sharing profits transparently with users, and offering a new service model. This innovative approach will solidify UNICE Labs' leading position in the global healthcare industry.

UNICE Lab anticipates creating significant social value by offering services in regions with scarce medical resources, particularly Southeast Asia. The experience and data collected in this region will serve as a basis for refining service provision strategies in Korea, Europe, America, and beyond. Based on these experiences, UNICE Lab plans to adjust and improve services according to the legal environments of different countries.

However, the adoption of such innovations faces limitations due to legal and policy constraints in many countries. In response, the UNICE team is continuously researching and developing to provide new types of medical services in various countries and is striving to harmonize with the policies of different nations. Monitoring the development and delivery methods of UNICE, which aims to increase accessibility to medical services worldwide and lead medical innovation, is crucial. These efforts will bear fruit, allowing many countries to benefit from the innovative services provided by UNICE.

For media inquiries, please contact:
contact@unicelab.io

Media Contact

Organization: unice lab
Contact Person: Jaden Jeon
Website: https://unicelab.io
Email: contact@unicelab.io
City: Seoul
Country: North Korea

SOURCE: unice lab



View the original press release on accesswire.com

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2024 ACCESSWIRE
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.